The labels can sound persuasive, but evidence for meaningful weight loss is often limited
Your provider can discuss how your genetic predispositions may inform expected response timelines, potential side effect tolerability, and whether a specific compounded formulation or protocol aligns with your biology
DR has served on an advisory panel and as an author for Bristol-Myers Squibb, Eli Lilly, Medtronic, Merck, Novartis, Novo Nordisk and Sanofi, and has served on an advisory panel and as speaker for AstraZeneca, Eli Lilly, Janssen, Novartis, Novo Nordisk and Sanofi
Important Information Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality
A 0.05mg microdose requires 2 units, tight but achievable